Supplementary figure 2 from WRN Promoter CpG Island Hypermethylation Does Not Predict More Favorable Outcomes for Patients with Metastatic Colorectal Cancer Treated with Irinotecan-Based Therapy

Autor:	William M. Grady, Beatriz Carvalho, Raymond J. Monnat, Gerrit A. Meijer, Wim van Criekinge, Cornelis J.A. Punt, Iris D. Nagtegaal, Miriam Koopman, James G. Herman, Piri Welcsh, Weiliang Tang, Sandra Mongera, Ilse Vlassenbroeck, Geert Trooskens, Petur Snaebjornsson, Victoria V. Lao, Yanxin Luo, Linda J.W. Bosch
Rok vydání:	2023
DOI:	10.1158/1078-0432.22454850
Popis:	Progression Free survival in metastatic CRC patients with unmethylated or methylated WRN promoter regions, in response to second line irinotecan (IRI) treatment in the sequential treatment arm (arm A).
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::91c4579c4881cb3bcaad2196b8d62e7c https://doi.org/10.1158/1078-0432.22454850 Zobrazit plný text záznamu